Boost Your Productivity!Translate documents (Ms-Word, Ms-Excel, ...) faster and better thanks to artificial intelligence!
https://pro.wordscope.com
https://blog. wordscope .com

Traduction de « 11 cc benefited from increasing » (Néerlandais → Français) :

Sandostatin (USD 312 million, +11% cc) benefited from increasing use of Sandostatin LAR in treating the symptoms of neuroendocrine tumors (NET).
http://www.novartis.be/downloa (...) (...) [HTML]
Sandostatine (USD 312 millions, +11% tcc) a bénéficié d’une utilisation accrue de Sandostatine LAR contre les tumeurs neuroendocrines (TNE).
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Sandostatin (USD 310 million, +14% cc) benefited from increasing use of Sandostatin LAR in neuroendocrine tumors (NET).
http://www.novartis.be/downloa (...) (...) [HTML]
Sandostatine (USD 310 millions, +14% tcc) a bénéficié d’une utilisation accrue de Sandostatine LAR contre les tumeurs neuroendocrines (TNE).
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Asia-Pacific (USD 2.2 billion, +18% cc) benefited from rapid expansion in key markets.
http://www.novartis.be/downloa (...) (...) [HTML]
L’Asie- Pacifique (USD 2,2 milliards, +18% tcc) a bénéficié d’une progression rapide de ses principaux marchés.
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Sandostatin (USD 539 million, +6% lc), for acromegaly and neuroendocrine tumors of the gastrointestinal tract and pancreas, benefited from increasing use of Sandostatin LAR, the once-monthly version that accounts for nearly 90% of net sales.
http://www.novartis.be/downloa (...) (...) [HTML]
Sandostatine (USD 539 millions, +6% en m. l.), traitement de l’acromégalie et de tumeurs neuroendocrines du tractus gastro-intestinal et du pancréas, a bénéficié d’une utilisation accrue de Sandostatine LAR, la version en administration mensuelle, qui compte pour près de 90% du chiffre d'affaires net.
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Pharmaceuticals: +69% to USD 1.6 billion Among factors contributing to the sharp rise in operating income were the markedly improved business performance and benefits from increased productivity as well as significantly lower exceptional charges.
http://www.novartis.be/downloa (...) (...) [HTML]
Pharmaceuticals: +69% à USD 1,6 milliard Parmi les facteurs ayant contribué au bond du résultat opérationnel, il y a l'amélioration notable des ventes et les bénéfices provenant de la hausse de la productivité ainsi qu'une baisse importante des charges exceptionnelles.
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Sandostatin (USD 318 million, +8% cc), a treatment for acromegaly, benefited from the increasing use of Sandostatin LAR in treating symptoms of patients with neuroendocrine tumors (NET).
http://www.novartis.be/downloa (...) (...) [HTML]
Sandostatine (USD 318 millions, +8% tcc), un traitement de l’acromégalie, a bénéficié d’une utilisation accrue de Sandostatine LAR contre les tumeurs neuroendocrines (TNE).
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Net income increased by 10% (+14% cc) to USD 2.3 billion, primarily benefitting from a gain on the revaluation of the initial 25% stake in Alcon of USD 204 million and the impact of exceptional charges made against associated companies in 2009.
http://www.novartis.be/downloa (...) (...) [HTML]
Le résultat net a augmenté de 10% (+14% tcc) à USD 2,3 milliards, bénéficiant notamment d’un gain d’USD 204 millions provenant de la réévaluation de la participation initiale de 25% dans Alcon et de l’impact de charges exceptionnelles enregistrées dans les entreprises associées en 2009.
http://www.novartis.be/downloa (...) (...) [HTML]
http://www.novartis.be/downloa (...) [HTML]
Table 2: Search for additional RCTs Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for RCT’s Date 27/04/2010 Keywords Breast neoplasms (MESH), mass screening (or early detection) (MESH), mammography (MESH) Medline 1 Randomized controlled trials/ (66083) Medline (OVID): (OVID): 2 Randomized controlled trial.pt (289038) Filter Filter 3 Random allocation/ (67885) RCT RCT 4 Double blind method/ (105956) 5 Single blind method/ (13834) 6 Clinical trial.pt (460563) 7 exp clinical trial/ (606505) 8 or/1-7 (718664) 9 (clinic$ adj trial$).tw ...[+++]
http://kce.fgov.be/sites/defau (...) (...) [HTML]
Table 4: Search for additional RCTs Search Benefit and harms of mammography screening (40-49 y) questions Note Specific search for RCT’s Date 27/04/2010 Keywords Breast neoplasms (MESH), mass screening (or early detection) (MESH), mammography (MESH) Medline 1 Randomized controlled trials/ (66083) Medline (OVID): (OVID): 2 Randomized controlled trial.pt (289038) Filter Filter 3 Random allocation/ (67885) RCT RCT 4 Double blind method/ (105956) 5 Single blind method/ (13834) 6 Clinical trial.pt (460563) 7 exp clinical trial/ (606505) 8 or/1-7 (718664) 9 (clinic$ adj trial$).tw ...[+++]
http://kce.fgov.be/sites/defau (...) (...) [HTML]
http://kce.fgov.be/sites/defau (...) [HTML]


D'autres ont cherché : +11 cc benefited     cc benefited from     benefited from increasing     +14 cc benefited     +18 cc benefited     pancreas benefited     benefited from     performance and benefits     benefits from     benefits from increased     for acromegaly benefited     from the increasing     primarily benefitting     primarily benefitting from     net income increased     rcts search benefit     from     mammography screening      11 cc benefited from increasing     


datacenter (28): www.wordscope.be (v4.0.br)

' 11 cc benefited from increasing' ->

Date index: 2023-01-07
w